EntityQ5745805· pop 5· linked from 3 articles

hesperadin

Hesperadin is an aurora kinase inhibitor.

Research

74 papers

Novel CaMKII-δ Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor Growth.Circulation · 2022
Hesperadin suppresses pancreatic cancer through ATF4/GADD45A axis at nanomolar concentrations.Oncogene · 2022
[Effect and molecular mechanism of hesperadin-induced ferroptosis in chronic myeloid leukemia K562 cells].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2024
Human Aurora kinase inhibitor Hesperadin reveals epistatic interaction between Plasmodium falciparum PfArk1 and PfNek1 kinases.Communications biology · 2020
MST4 Kinase Inhibitor Hesperadin Attenuates Autophagy and Behavioral Disorder via the MST4/AKT Pathway in Intracerebral Hemorrhage Mice.Behavioural neurology · 2020

via PubMed

Article

1 sections

Contents

References

{{chembox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 443873334 | ImageFile = hesperadin.svg | ImageClass = skin-invert-image | ImageSize=200px | PIN=N-[(3Z)-2-Oxo-3-(phenyl{4-[(piperidin-1-yl)methyl]anilino}methylidene)-2,3-dihydro-1H-indol-5-yl]ethanesulfonamide | OtherNames= |Section1= |Section2= |Section3= }}

Hesperadin is an aurora kinase inhibitor.